Enrichment of Human Embryonic Stem Cell-derived NKX6.1-expressing Pancreatic Progenitor Cells Accelerates the Maturation of Insulin-secreting Cells in Vivo
Overview
Reproductive Medicine
Authors
Affiliations
Human embryonic stem cells (hESCs) are considered a potential alternative to cadaveric islets as a source of transplantable cells for treating patients with diabetes. We previously described a differentiation protocol to generate pancreatic progenitor cells from hESCs, composed of mainly pancreatic endoderm (PDX1/NKX6.1-positive), endocrine precursors (NKX2.2/synaptophysin-positive, hormone/NKX6.1-negative), and polyhormonal cells (insulin/glucagon-positive, NKX6.1-negative). However, the relative contributions of NKX6.1-negative versus NKX6.1-positive cell fractions to the maturation of functional β-cells remained unclear. To address this question, we generated two distinct pancreatic progenitor cell populations using modified differentiation protocols. Prior to transplant, both populations contained a high proportion of PDX1-expressing cells (~85%-90%) but were distinguished by their relatively high (~80%) or low (~25%) expression of NKX6.1. NKX6.1-high and NKX6.1-low progenitor populations were transplanted subcutaneously within macroencapsulation devices into diabetic mice. Mice transplanted with NKX6.1-low cells remained hyperglycemic throughout the 5-month post-transplant period whereas diabetes was reversed in NKX6.1-high recipients within 3 months. Fasting human C-peptide levels were similar between groups throughout the study, but only NKX6.1-high grafts displayed robust meal-, glucose- and arginine-responsive insulin secretion as early as 3 months post-transplant. NKX6.1-low recipients displayed elevated fasting glucagon levels. Theracyte devices from both groups contained almost exclusively pancreatic endocrine tissue, but NKX6.1-high grafts contained a greater proportion of insulin-positive and somatostatin-positive cells, whereas NKX6.1-low grafts contained mainly glucagon-expressing cells. Insulin-positive cells in NKX6.1-high, but not NKX6.1-low grafts expressed nuclear MAFA. Collectively, this study demonstrates that a pancreatic endoderm-enriched population can mature into highly functional β-cells with only a minor contribution from the endocrine subpopulation.
Mu-U-Min R, Diane A, Allouch A, Al-Siddiqi H Biomedicines. 2025; 13(2).
PMID: 40002796 PMC: 11853723. DOI: 10.3390/biomedicines13020383.
Current Challenges in Pancreas and Islet Transplantation: A Scoping Review.
Altabas V, Bulum T Biomedicines. 2025; 12(12).
PMID: 39767759 PMC: 11673013. DOI: 10.3390/biomedicines12122853.
Tornabene P, Wells J Eur J Cell Biol. 2024; 103(4):151464.
PMID: 39486145 PMC: 11840517. DOI: 10.1016/j.ejcb.2024.151464.
Pancreatic islet transplantation: current advances and challenges.
Wang Q, Huang Y, Liu L, Zhao X, Sun Y, Mao X Front Immunol. 2024; 15:1391504.
PMID: 38887292 PMC: 11180903. DOI: 10.3389/fimmu.2024.1391504.
Marques J, Nunes R, Carvalho A, Florindo H, Ferreira D, Sarmento B ACS Pharmacol Transl Sci. 2024; 7(5):1650-1663.
PMID: 38751616 PMC: 11092009. DOI: 10.1021/acsptsci.4c00173.